InterChem

InterChem

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

InterChem is a private, revenue-generating services company that facilitates pharmaceutical development and commercialization by managing complex API and antibiotic supply chains. It positions itself as a risk-mitigating partner, offering sourcing, custom manufacturing coordination, and logistics support built on over 40 years of collective industry experience. The company's model is built on deep supplier relationships and regulatory knowledge to accelerate clients' time-to-market. Its operations appear focused on the backend of pharmaceutical production rather than internal drug discovery.

Small MoleculesDrug Delivery

Technology Platform

Integrated pharmaceutical supply chain services platform built on a vetted global supplier network, regulatory/compliance expertise, and logistics management.

Funding History

2
Total raised:$20M
Series A$15M
Seed$5M

Opportunities

Growth is driven by the expanding and outsourcing biopharma sector, especially virtual biotechs needing external supply chain expertise.
Increased focus on supply chain resilience and redundancy post-pandemic creates demand for reliable, managed partners like InterChem.

Risk Factors

Key risks include supply chain disruption from geopolitical events or supplier failures, regulatory compliance lapses leading to liability, and customer concentration.
The business is also vulnerable to competition in the fragmented pharmaceutical services space.

Competitive Landscape

InterChem competes in a fragmented market including large chemical distributors (e.g., Sigma-Aldrich), specialized API suppliers, and niche logistics firms. Its differentiation is its deep, veteran-led expertise in pharmaceutical-grade sourcing and regulatory navigation, targeting clients who value risk mitigation over lowest cost.